The Congenital Hyperinsulinism market was valued at USD 163.97 Billion in 2024 and is expected to reach USD 425.22 Billion by 2032, growing at a CAGR of 12.65% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.